Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Beam Therapeutics Inc. (BEAM) had Free Cash Flow per Share of $-1.83 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$8.47M |
|
$-102.29M |
|
-- |
|
$8.47M |
|
$128.62M |
|
$-120.15M |
|
$17.86M |
|
$-102.29M |
|
$-102.29M |
|
$-102.29M |
|
$-102.29M |
|
$-102.29M |
|
$-102.29M |
|
$-120.15M |
|
$-119.23M |
|
102.00M |
|
102.00M |
|
$-1.00 |
|
$-1.00 |
|
| Balance Sheet Financials | |
$1.18B |
|
$108.82M |
|
$215.69M |
|
$1.39B |
|
$174.13M |
|
-- |
|
$170.21M |
|
$344.34M |
|
$1.05B |
|
$1.05B |
|
$1.05B |
|
100.76M |
|
| Cash Flow Statement Financials | |
$-180.33M |
|
$-295.50M |
|
$474.49M |
|
$290.11M |
|
$288.76M |
|
$-1.35M |
|
$51.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1419.22% |
|
-1419.22% |
|
-- |
|
-1208.26% |
|
-1208.26% |
|
$-186.53M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-9.77% |
|
-9.77% |
|
-7.35% |
|
-9.77% |
|
$10.39 |
|
|
Free Cash Flow per Share |
$-1.83 |
$-1.77 |
|